ORP

OrpeaENXTPA:ORP Stock Report

Market Cap

€6.7b

7D

-0.6%

1Y

4.0%

Updated

18 Sep, 2021

Data

Company Financials +
ORP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance1/6
Financial Health0/6
Dividends3/6

ORP Overview

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

Orpea Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orpea
Historical stock prices
Current Share Price€104.30
52 Week High€83.30
52 Week Low€119.80
Beta0.80
1 Month Change1.12%
3 Month Change-3.16%
1 Year Change4.04%
3 Year Change-6.67%
5 Year Change31.00%
Change since IPO1,348.61%

Recent News & Updates

Aug 20
Orpea (EPA:ORP) Will Be Hoping To Turn Its Returns On Capital Around

Orpea (EPA:ORP) Will Be Hoping To Turn Its Returns On Capital Around

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Jun 16
Here's Why Orpea SA's (EPA:ORP) CEO Compensation Is The Least Of Shareholders Concerns

Here's Why Orpea SA's (EPA:ORP) CEO Compensation Is The Least Of Shareholders Concerns

Shareholders may be wondering what CEO Yves Le Masne plans to do to improve the less than great performance at Orpea SA...

Jun 02
Estimating The Intrinsic Value Of Orpea SA (EPA:ORP)

Estimating The Intrinsic Value Of Orpea SA (EPA:ORP)

How far off is Orpea SA ( EPA:ORP ) from its intrinsic value? Using the most recent financial data, we'll take a look...

May 19
Orpea (EPA:ORP) Will Be Hoping To Turn Its Returns On Capital Around

Orpea (EPA:ORP) Will Be Hoping To Turn Its Returns On Capital Around

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...

May 06
Should You Investigate Orpea SA (EPA:ORP) At €106?

Should You Investigate Orpea SA (EPA:ORP) At €106?

Orpea SA ( EPA:ORP ), might not be a large cap stock, but it received a lot of attention from a substantial price...

Shareholder Returns

ORPFR HealthcareFR Market
7D-0.6%-0.8%-1.8%
1Y4.0%5.3%32.8%

Return vs Industry: ORP underperformed the French Healthcare industry which returned 5.3% over the past year.

Return vs Market: ORP underperformed the French Market which returned 32.8% over the past year.

Price Volatility

Is ORP's price volatile compared to industry and market?
ORP volatility
ORP Beta0.80
Industry Beta0.97
Market Beta1

Stable Share Price: ORP is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: ORP's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198954,424Yves Le Masnehttps://www.orpea-corp.com

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state.

Orpea Fundamentals Summary

How do Orpea's earnings and revenue compare to its market cap?
ORP fundamental statistics
Market Cap€6.74b
Earnings (TTM)€160.05m
Revenue (TTM)€3.92b

42.1x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ORP income statement (TTM)
Revenue€3.92b
Cost of Revenue€2.96b
Gross Profit€963.25m
Expenses€803.20m
Earnings€160.05m

Last Reported Earnings

Dec 31, 2020

Next Earnings Date

Sep 21, 2021

Earnings per share (EPS)2.48
Gross Margin24.56%
Net Profit Margin4.08%
Debt/Equity Ratio217.3%

How did ORP perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

36%

Payout Ratio

Valuation

Is Orpea undervalued compared to its fair value and its price relative to the market?

42.1x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ORP (€104.3) is trading above our estimate of fair value (€63.32)

Significantly Below Fair Value: ORP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ORP is poor value based on its PE Ratio (42.1x) compared to the French Healthcare industry average (36.3x).

PE vs Market: ORP is poor value based on its PE Ratio (42.1x) compared to the French market (21.2x).


Price to Earnings Growth Ratio

PEG Ratio: ORP is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: ORP is good value based on its PB Ratio (1.9x) compared to the FR Healthcare industry average (2.2x).


Future Growth

How is Orpea forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

17.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORP's forecast earnings growth (17.7% per year) is above the savings rate (0.4%).

Earnings vs Market: ORP's earnings (17.7% per year) are forecast to grow faster than the French market (12.2% per year).

High Growth Earnings: ORP's earnings are forecast to grow, but not significantly.

Revenue vs Market: ORP's revenue (6.8% per year) is forecast to grow faster than the French market (6.2% per year).

High Growth Revenue: ORP's revenue (6.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORP's Return on Equity is forecast to be low in 3 years time (8%).


Past Performance

How has Orpea performed over the past 5 years?

3.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORP has a large one-off gain of €129.1M impacting its December 31 2020 financial results.

Growing Profit Margin: ORP's current net profit margins (4.1%) are lower than last year (6.2%).


Past Earnings Growth Analysis

Earnings Trend: ORP's earnings have grown by 3.8% per year over the past 5 years.

Accelerating Growth: ORP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ORP had negative earnings growth (-31.5%) over the past year, making it difficult to compare to the Healthcare industry average (31.2%).


Return on Equity

High ROE: ORP's Return on Equity (4.6%) is considered low.


Financial Health

How is Orpea's financial position?


Financial Position Analysis

Short Term Liabilities: ORP's short term assets (€2.4B) do not cover its short term liabilities (€2.6B).

Long Term Liabilities: ORP's short term assets (€2.4B) do not cover its long term liabilities (€10.8B).


Debt to Equity History and Analysis

Debt Level: ORP's debt to equity ratio (217.3%) is considered high.

Reducing Debt: ORP's debt to equity ratio has increased from 200.5% to 217.3% over the past 5 years.

Debt Coverage: ORP's debt is not well covered by operating cash flow (10.3%).

Interest Coverage: ORP's interest payments on its debt are not well covered by EBIT (2.2x coverage).


Balance Sheet


Dividend

What is Orpea current dividend yield, its reliability and sustainability?

0.86%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ORP's dividend (0.86%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.27%).

High Dividend: ORP's dividend (0.86%) is low compared to the top 25% of dividend payers in the French market (3.88%).


Stability and Growth of Payments

Stable Dividend: ORP's dividend payments have been volatile in the past 10 years.

Growing Dividend: ORP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (36.3%), ORP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: ORP's dividends in 3 years are forecast to be well covered by earnings (33.3% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average board tenure


CEO

Yves Le Masne (59 yo)

10.58yrs

Tenure

€1,978,036

Compensation

Mr. Yves Le Masne has been the Chief Executive Officer of Orpea SA since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le Masne served...


CEO Compensation Analysis

Compensation vs Market: Yves's total compensation ($USD2.32M) is about average for companies of similar size in the French market ($USD2.55M).

Compensation vs Earnings: Yves's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: ORP's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Orpea SA's employee growth, exchange listings and data sources


Key Information

  • Name: Orpea SA
  • Ticker: ORP
  • Exchange: ENXTPA
  • Founded: 1989
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €6.737b
  • Shares outstanding: 64.59m
  • Website: https://www.orpea-corp.com

Number of Employees


Location

  • Orpea SA
  • 12, rue Jean-Jaurès
  • CS 10032
  • Puteaux
  • Ile-de-France
  • 92813
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/18 17:32
End of Day Share Price2021/09/17 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.